Based on the literature data showing that LEN exerts the anti-MM activity through the selective ubiquitination and degradation of Cereblon targets, Ikaros and Aiolos [12], we assessed the protein levels of Cereblon, Ikaros and Aiolos on LEN-treated THP1-DCs. The gene discussed is CRBN; the disease is Miyoshi myopathy.